Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Cullgen

Cullgen IPO

$264.09MM
Series C Valuation, May 2023
Register for details
For more details on financing and valuation of private companies similar to Cullgen before its M&A, register or log in today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

Cullgen IPO date and status

2018
Founded
Nov 2024
MA Announced
May 2026
MA Closed

Company details

Cullgen, founded in 2018, is a biopharmaceutical company that develops new chemical entities (NCEs) designed to treat diseases that lack effective therapeutic approaches. Using its proprietary uSMITE™ platform, the company expands on the drug design paradigm aiming to target proteins that are typically resistant to treatments for selective destruction. Cullgen has produced several highly potent, selective, and bioavailable targeted protein degrader compounds. Cullgen is headquartered in San Diego, California.
Founded
2018
Headquarters
San Diego, CA, United States
Founders
Jian Jin, Ph.D., Yue Xiong, Ph.D.
Forge Price 1
Price not available
Market Activity 2
Limited
Last Matched Price
Post-Money Valuation 3
$264.09MM
Total Funding
$116MM
Last Funding Round
Series C

Learn more about Cullgen

To invest in Cullgen pre-IPO

Can you invest in Cullgen pre-IPO?

You can no longer invest in Cullgen with Forge. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Cullgen before it goes public?

You can no longer sell shares of Cullgen on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Cullgen shares?

Forge can no longer determine the value of Cullgen shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Cullgen a publicly traded company?

Cullgen became a public company following its M&A on 05/04/2026 and is now a publicly traded company.

To learn more about Cullgen potential IPO

Will Cullgen go IPO?

Cullgen became a public company following its M&A on 05/04/2026.

What is Cullgen’s IPO price?

The IPO price of Cullgen is not currently available.

When was Cullgen founded?

Cullgen was founded in 2018.

What is Cullgen funding to date?

Cullgen has raised $116MM to date.

Cullgen major investors

3e Bioventures Capital
Gni Group
Heights Capital Management
Highlight Capital
Msa Capital
Octagon Capital Advisors
Sequoia Capital China
Shenzhen Investment
Sincere Capital
Sirius Holding Group
South China Venture Capital
Voyagers Capital
Wuxi Capital Group

Cullgen pre-IPO valuation and funding rounds

Funding history chart
Funding round and deals details
Funding Date Round Amount Raised Price per Share Post-Money Valuation 3 Key Investors
05/08/2023 Series C $35MM $2.63 $264.09MM Astrazeneca-Ciccventurecapitalpartnership, Ghigroup, Sincerecapital, Voyagerscapital, Wuxicapitalgroup
Price per Share
$ xx.xx
Shares Outstanding
13,329,269
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Astrazeneca-Ciccventurecapitalpartnership, Ghigroup, Sincerecapital, Voyagerscapital, Wuxicapitalgroup
02/25/2021 Series B $50MM $2.49 $184.64MM 3ebioventurescapital, Heightscapitalmanagement, Msacapital, Octagoncapital, Southchinaventurecapital
Price per Share
$ xx.xx
Shares Outstanding
20,080,321
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
3ebioventurescapital, Heightscapitalmanagement, Msacapital, Octagoncapital, Southchinaventurecapital
04/10/2019 Series A $16MM $1.70 $75.45MM Highlightcapital, Sequoiacapital
Price per Share
$ xx.xx
Shares Outstanding
9,411,765
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Highlightcapital, Sequoiacapital
03/10/2018 Series Seed-1 $10MM $1.00 $30MM Gnigroup
Price per Share
$ xx.xx
Shares Outstanding
10,000,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Gnigroup
03/10/2018 Series Seed-2 $5MM $1.00 $30MM Gnigroup
Price per Share
$ xx.xx
Shares Outstanding
5,000,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Gnigroup

Cullgen IPO news and media highlights

Cullgen Raises $40 Million in New Financing Led by AstraZeneca-CICC Fund

Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, today announced that it has raised $40 million in new financing.
Browse More Insights

Private companies exploring an IPO

See which private companies are preparing for the public market. Register to get full access to the latest secondary market pricing data.

Sector: Healthcare
Subsector: Biotech & Pharma
Trade Metrics Last Funding Round
Company Forge Price Last Matched Round Post-Money Valuation 3 Price Per Share Amount Raised
Odyssey TherapeuticsOdyssey TherapeuticsNot available$ xx.xxSeries D$527.3MM$14.62$213.63MM
Affinia TherapeuticsAffinia TherapeuticsNot available$ xx.xxSeries C$156.61MM$1.62$40MM
OriginOriginNot available$ xx.xxNot available------

Private market movers

Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.

Actively traded

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $264.57 +$5.43 (2.10%)High $xxx.xx
SpaceX SpaceX $634.05 +$1.08 (0.17%)High $xxx.xx
OpenAI OpenAI $715.37 -$13.58 (1.86%)High $xxx.xx
Cerebras Cerebras $113.50 +$11.16 (10.90%)High $xxx.xx
Anduril Anduril $112.24 +$0.69 (0.62%)High $xxx.xx

Artificial Intelligence (AI)

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $264.57 +$5.43 (2.10%)High $xxx.xx
OpenAI OpenAI $715.37 -$13.58 (1.86%)High $xxx.xx
Anduril Anduril $112.24 +$0.69 (0.62%)High $xxx.xx
Databricks Databricks $196.31 -$0.07 (0.04%)High $xxx.xx
Figure AI Figure AI $174.00 -$20.00 (10.31%)Limited $xxx.xx

Forge, your trusted partner for pre-IPO insights and Cullgen data

Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Updated on: May 8, 2026

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.